The level of DNA platination in cisplatin-treated cells could be indicative for the balance between cellular cisplatin import and its compensatory export via drug efflux pumps, such as MRP1, which is typically overexpressed in chemotherapy-resistant ovarian cancer [36]. This evidence concerns the gene ABCC1 and ovarian carcinoma.